Long-term Mortality in HIV-Positive Individuals Virally Suppressed for > 3 Years With Incomplete CD4 Recovery


Por: Engsig, FN, Zangerle, R, Katsarou, O, Dabis, F, Reiss, P, Gill, J, Porter, K, Sabin, C, Riordan, A, Fatkenheuer, G, Gutierrez, F, Raffi, F, Kirk, O, Mary-Krause, M, Stephan, C, de Olalla, PG, Guest, J, Samji, H, Castagna, A, Monforte, AD, Skaletz-Rorowski, A, Ramos, J, Lapadula, G, Mussini, C, Force, L, Meyer, L, Lampe, F, Boufassa, F, Bucher, HC, De Wit, S, Burkholder, GA, Teira, R, Justice, AC, Sterling, TR, Crane, HM, Gerstoft, J, Grarup, J, May, M, Chene, G, Ingle, SM, Sterne, J, Obel, N

Publicada: 1 may 2014
Resumen:
Background. Some human immunodeficiency virus (HIV)-infected individuals initiating combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression but not CD4 cell recovery. We aimed to identify (1) risk factors for failure to achieve CD4 count >200 cells/mu L after 3 years of sustained viral suppression and (2) the association of the achieved CD4 count with subsequent mortality. Methods. We included treated HIV-infected adults from 2 large international HIV cohorts, who had viral suppression (<= 500 HIV type 1 RNA copies/mL) for >3 years with CD4 count <= 200 cells/mu L at start of the suppressed period. Logistic regression was used to identify risk factors for incomplete CD4 recovery (<= 200 cells/mu L) and Cox regression to identify associations with mortality. Results. Of 5550 eligible individuals, 835 (15%) did not reach a CD4 count >200 cells/mu L after 3 years of suppression. Increasing age, lower initial CD4 count, male heterosexual and injection drug use transmission, cART initiation after 1998, and longer time from initiation of cART to start of the virally suppressed period were risk factors for not achieving a CD4 count >200 cells/mu L. Individuals with CD4 <= 200 cells/mu L after 3 years of viral suppression had substantially increased mortality (adjusted hazard ratio, 2.60; 95% confidence interval, 1.86-3.61) compared with those who achieved CD4 count >200 cells/mu L. The increased mortality was seen across different patient groups and for all causes of death. Conclusions. Virally suppressed HIV-positive individuals on cART who do not achieve a CD4 count >200 cells/mu L have substantially increased long-term mortality.

Filiaciones:
Engsig, FN:
 Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark

 Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark

Zangerle, R:
 Med Univ Innsbruck, Dept Dermatol & Venerol, A-6020 Innsbruck, Austria

Katsarou, O:
 Laikon Gen Hosp, Ctr Blood, Athens, Greece

 Laikon Gen Hosp, Natl Reference Ctr Congenital Bleeding Disorders, Athens, Greece

Dabis, F:
 Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France

Reiss, P:
 Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

 Stichting HIV Monitoring, Amsterdam, Netherlands

Gill, J:
 Univ Calgary, Dept Med, Calgary, AB T2N 1N4, Canada

Porter, K:
 MRC Clin Trials Unit, London, England

Sabin, C:
 UCL, Res Dept Infect & Populat Hlth, London WC1E 6BT, England

Riordan, A:
 Alder Hey Childrens NHS Fdn Trust, Dept Paediat Infect Dis & Immunol, Liverpool, Merseyside, England

Fatkenheuer, G:
 Univ Cologne, Dept Internal Med 1, Cologne, Germany

Gutierrez, F:
 Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain

Raffi, F:
 Hotel Dieu Univ Hosp, Dept Infect Dis, Nantes, France

 Hotel Dieu Univ Hosp, HIV Clin Res Unit, Nantes, France

Kirk, O:
 Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark

 Univ Copenhagen, Panum Inst, Copenhagen HIV Programme, DK-2100 Copenhagen O, Denmark

Mary-Krause, M:
 Univ Paris 06, INSERM, Unite Mixte Rech Sante 943, Hop La Pitie Salpetriere, Paris, France

Stephan, C:
 Goethe Univ Hosp, Dept Infect Dis, Frankfurt, Germany

de Olalla, PG:
 Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain

Guest, J:
 Atlanta Vet Affairs Med Ctr, Atlanta, GA USA

Samji, H:
 British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada

Castagna, A:
 Ist Sci San Raffaele, Dept Infect & Trop Dis, I-20132 Milan, Italy

Monforte, AD:
 San Paolo Univ Hosp, Dept Hlth Sci, Infect Dis Unit, Milan, Italy

Skaletz-Rorowski, A:
 Ruhr Univ Bochum, Competence Network HIV AIDS, Bochum, Germany

Ramos, J:
 Hosp Univ Getafe, Dept Pediat, Madrid, Spain

Lapadula, G:
 Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy

Mussini, C:
 Med Specialties Univ Modena & Reggio Emilia, Dept Internal Med, Clin Infect Dis, Modena, Italy

Force, L:
 Hosp de Mataro, Infect Dis Unit, Barcelona, Spain

Meyer, L:
 Hop Bicetre, AP HP, Serv Epidemiol & Sante Publ, Paris, France

 INSERM, U1018, F-75654 Paris 13, France

 Univ Paris 11, Paris, France

Lampe, F:
 UCL, Res Dept Infect & Populat Hlth, London WC1E 6BT, England

Boufassa, F:
 Univ Paris 11, INSERM, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol HIV & STI Team, Le Kremlin Bicetre, France

Bucher, HC:
 Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland

De Wit, S:
 St Pierre Univ Hosp, Dept Infect Dis, Brussels, Belgium

Burkholder, GA:
 Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA

Teira, R:
 Hosp Sierrallana Torrelavega, Med Interna Serv, Cantabria, Spain

Justice, AC:
 Veterans Affairs Connecticut Healthcare Syst, West Haven, CT USA

 Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA

Sterling, TR:
 Vanderbilt Univ, Sch Med, Div Infect Dis, Nashville, TN 37212 USA

Crane, HM:
 Univ Washington, Ctr AIDS Res, Clin Epidemiol & Hlth Serv Res Core, Seattle, WA 98195 USA

Gerstoft, J:
 Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark

Grarup, J:
 Univ Copenhagen, Panum Inst, Copenhagen HIV Programme, DK-2100 Copenhagen O, Denmark

May, M:
 Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England

Chene, G:
 Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France

Ingle, SM:
 Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England

Sterne, J:
 Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England

Obel, N:
 Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark
ISSN: 10584838





CLINICAL INFECTIOUS DISEASES
Editorial
OXFORD UNIV PRESS INC, JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 58 Número: 9
Páginas: 1312-1321
WOS Id: 000335006900018
ID de PubMed: 24457342
imagen Bronze, Green Published

MÉTRICAS